# The Effect of Application of TachoSil® in Pancreatoduodenectomy

> **NCT03269955** · PHASE4 · UNKNOWN · sponsor: **Asan Medical Center** · enrollment: 126 (estimated)

## Conditions studied

- Pancreatic Neoplasm
- Pancreatic Periampullary Cancer
- Pancreatic Bordeline Tumor

## Interventions

- **DRUG:** Fibrinogen/thrombin-coated collagen patch

## Key facts

- **NCT ID:** NCT03269955
- **Lead sponsor:** Asan Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-02-27
- **Primary completion:** 2018-05
- **Final completion:** 2018-05
- **Target enrollment:** 126 (ESTIMATED)
- **Last updated:** 2017-09-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03269955

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03269955, "The Effect of Application of TachoSil® in Pancreatoduodenectomy". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03269955. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*